35 filings
6-K
Avidity Biosciences Inc
12 Feb 15
Current report (foreign)
12:00am
6-K
Avidity Biosciences Inc
10 Feb 15
Prosensa Announces Voluntary Delisting and Advance Liquidation Distribution
12:00am
6-K
Avidity Biosciences Inc
30 Jan 15
Prosensa Announces Intent to Voluntarily Delist from NASDAQ
12:00am
6-K
Avidity Biosciences Inc
15 Jan 15
Current report (foreign)
12:00am
6-K
Avidity Biosciences Inc
13 Jan 15
Prosensa Announces Shareholder Approval of Certain Matters Relating to the BioMarin Tender Offer
12:00am
6-K
hr0ye0v
9 Dec 14
Prosensa Wins Scrip ‘Biotech Company of the Year’ 2014 Award
12:00am
6-K
1wcbt3eclc0qdpp4i
9 Dec 14
Current report (foreign)
12:00am
6-K
ci74q5gra 8s47vkj
26 Nov 14
Current report (foreign)
12:00am
6-K
aiu0tk3
24 Nov 14
Current report (foreign)
12:00am
6-K
qjexbvcps
17 Nov 14
Form 6-K Filing Document
12:00am
6-K
qu54lu46 q4k8dmibm
17 Nov 14
Current report (foreign)
12:00am
6-K
vh40viha3u 8fw0w
16 Oct 14
Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne muscular dystrophy
12:00am
6-K
esp27mntbfmwb5m0jyv
21 Aug 14
Current report (foreign)
12:00am
6-K
xs99rjvzcx4
14 Aug 14
Form 6-K Filing Document
12:00am
6-K
79p7c1
12 Aug 14
Current report (foreign)
12:00am
6-K
ungy xtoaz
14 Jul 14
Current report (foreign)
12:00am
6-K
sxddsr
30 Jun 14
Form 6-K Filing Document
12:00am
6-K
l1utm m26n2f6k
20 Jun 14
Current report (foreign)
12:00am
6-K
tma1kgxd8 7abotnas6
3 Jun 14
Current report (foreign)
12:00am
6-K
bt3ma ntrtb1uu0
20 May 14
Current report (foreign)
12:00am